Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
2.
Aust N Z J Med ; 9(3): 310-3, 1979 Jun.
Article in English | MEDLINE | ID: mdl-223536

ABSTRACT

The association of chronic liver disease with long-standing arsenic ingestion is well documented, although the spectrum and incidence of liver disease due to arsenic remain uncertain. We report two patients with chronic liver disease and arsenical skin changes that followed previous chronic arsenic ingestion. One patient developed macronodular cirrhosis and the other non-cirrhotic portal hypertension with perisinusoidal fibrosis. The latter patient developed a primary liver cell cancer. There is only one previously reported case of malignant hepatoma in a non-cirrhotic liver complicating chronic arsenicism. Lack of awareness of this uncommon but well described cause of chronic liver disease may account for a small proportion of patients with "cryptogenic" liver disease. Previous arsenic administration should be considered as a cause of chronic liver disease, especially when typical skin changes or internal neoplasia develop.


Subject(s)
Arsenic/adverse effects , Carcinoma, Hepatocellular/chemically induced , Liver Cirrhosis/chemically induced , Liver Neoplasms/chemically induced , Carcinoma, Basal Cell/chemically induced , Humans , Keratosis/chemically induced , Male , Middle Aged , Skin Neoplasms/chemically induced
4.
Med J Aust ; 1(1): 1-2, 1979 Jan 13.
Article in English | MEDLINE | ID: mdl-763184

ABSTRACT

Sixty patients with benign chronic gastric ulcer were treated in a controlled clinical trial to assess the relative efficacy of cimetidine and tri-potassium di-citrato bismuthate (De-Nol). Patients were assigned at random either to cimetidine or to De-Nol treatment after initial endoscopic diagnosis. Healing was assessed endoscopically after six weeks by an endoscopist who had no knowledge of the patients' treatment. Consumption of analgesic preparations (both for medical and for non-medical reasons), of other anti-inflammatory agents, and of alcohol and cigarettes was recorded. Of the 57 patients who were reassessed at six weeks, 30 had been assigned to De-Nol and 20 of these patients (66%) had completely healed; 27 patients had been assigned to cimetidine and 17 of these (63%) had also completely healed. Those patients who regularly ingested more than four analgesic preparations a day healed less frequently, but this effect was not statistically significant. There was no significant difference between cimetidine and De-Nol in the initial healing of chronic gastric ulceration. The choice of therapy for chronic gastric ulceration will depend on cost, patient acceptance, and data from studies of more complex therapeutic regimens.


Subject(s)
Bismuth/therapeutic use , Cimetidine/therapeutic use , Guanidines/therapeutic use , Stomach Ulcer/drug therapy , Analgesics/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Chronic Disease , Citrates/therapeutic use , Female , Gastroscopy , Humans , Male , Organometallic Compounds , Prospective Studies , Random Allocation , Stomach Ulcer/diagnosis , Stomach Ulcer/pathology
5.
Gut ; 19(6): 538-42, 1978 Jun.
Article in English | MEDLINE | ID: mdl-680587

ABSTRACT

The relationship between the serum ferritin concentration and total body iron stores was investigated in 41 patients with idiopathic haemochromatosis and 199 first or second degree relatives. Thirty-two relatives (16.1%) had increased iron stores and serum ferritin levels were increased in all but one of them. The false-positive rate in the relatives with normal iron stores was 1.8% compared with 10% for the serum iron concentration and 33% for the transferrin saturation. There was a significant correlation between the serum ferritin concentration and both the chelatable body iron and the hepatic iron concentration. We conclude that in the natural history of classical idiopathic haemochromatosis the serum ferritin concentration is usually raised when hepatic iron stores are increased and before there is architectural damage to the liver.


Subject(s)
Ferritins/blood , Hemochromatosis/metabolism , Iron/metabolism , Adolescent , Adult , Aged , Child , Hemochromatosis/genetics , Humans , Liver/metabolism , Middle Aged
6.
Lancet ; 2(8039): 621-4, 1977 Sep 24.
Article in English | MEDLINE | ID: mdl-71445

ABSTRACT

242 members of 43 families with idiopathic haemochromatosis were investigated for increased body-iron stores in order to assess the value of serum-ferritin determination as a screening-test to detect preclinical disease. The serum-iron concentration was elevated in only 76% of relatives with increased iron stores, and it was also elevated in 10% of relatives with normal iron stores. The percentage saturation of transferrin was elevated in all relatives with increased iron stores but also in 33% of relatives with normal iron stores. Serum-ferritin was raised in 98% of relatives with increased iron stores and in only 3 (1.8%) of those with normal iron stores. These 3 subjects consumed alcohol in excess of 100 g ethanol per day, and their serum-ferritin levels fluctuated widely. Increased iron stores were reflected in increased serum-ferritin concentrations in subjects as young as 14 years in whom the liver-iron concentration was twice the normal upper limit and before there was any evidence of architectural damage to the liver. The serum-ferritin concentration is a useful non-invasive screening test for precirrhotic haemochromatosis.


Subject(s)
Ferritins/blood , Hemochromatosis/diagnosis , Adolescent , Adult , Aged , Aspartate Aminotransferases/blood , Binding Sites , Child , Female , Hemochromatosis/blood , Hemochromatosis/genetics , Humans , Iron/metabolism , Liver/metabolism , Liver/pathology , Liver Cirrhosis/prevention & control , Male , Middle Aged , Transferrin/analysis
7.
Appl Microbiol ; 29(2): 234-9, 1975 Feb.
Article in English | MEDLINE | ID: mdl-803818

ABSTRACT

Plectonema boryanum, a filamentous blue-green alga, was cloned and then allowed to reach a steady state in a quasi-continuous culture in the presence of the algal virus, LPP-1. The culture was maintained for 3.5-month period during which time at least four distinct culture lysings were evident. After the fourth lysis the culture reached a steady-state level which was identical in its algal concentration to the preinfection level. Upon testing the characteristics of the evolved alga and virus variants, the following was determined: cell variants resistant to both the original virus and the derived virus had evolved, and there was no evidence of lysogeny present amony these cells. The evolved virus strains still grew on the parental algal strain, though with altered plaque morphology. Furthermore, they were antigenically similar to the parental virus, and showed no significant difference in adsorption rate or growth characteristics on parental cells. However, a low-grade chronic viral infection persisted in the culture. Rapid re-establishment of a dense, stable culture is apparantly the normal laboratory response of a procaryotic cell-virus system.


Subject(s)
Cyanobacteria/growth & development , Plant Viruses/growth & development , Adsorption , Antigens, Viral , Genetic Variation , Lysogeny , Neutralization Tests , Plant Viruses/immunology , Spectrophotometry , Viral Plaque Assay , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...